Xeris Biopharma Holdings, Inc. XERS Gross Profit
Discontinued — last reported Q1 '26
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s gross profit?
- Xeris Biopharma Holdings, Inc. (XERS) reported gross profit of $72.55M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s gross profit changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s gross profit increased by 41.2% year-over-year, from $51.39M to $72.55M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s gross profit?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s gross profit has grown at a 61.9% compound annual growth rate (CAGR), from $36.27M to $249.28M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.